文献速递主动脉疾病

糖尿病对EVAR与开放腹主动脉瘤修复术后短期和长期结局的影响:系统综述与Meta分析

Impact of Diabetes Mellitus on Short- and Long-Term Outcomes after EVAR and Open Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-02-17

该系统综述与Meta分析纳入14项观察性队列研究共149,206例患者(糖尿病30,328例),评估糖尿病与腹主动脉瘤修复术后结局的关联。糖尿病与总体30天或5年死亡率无关,但EVAR亚组中糖尿病患者30天死亡率更高,而OSR亚组无差异;5年死亡率在EVAR或OSR队列中均无差异。EVAR后糖尿病与5年再干预需求降低相关,但1年无差异,内漏率相似。

要点

  • 糖尿病与AAA修复术后总体30天和5年死亡率无关。
  • EVAR糖尿病患者30天死亡率更高,OSR糖尿病患者无此差异。
  • EVAR后糖尿病与5年再干预需求降低相关,内漏率相似。

核心结论

  • 糖尿病与AAA修复术后总体短期或长期结局恶化无关。
  • EVAR糖尿病患者早期死亡率更高,但长期结局与OSR相当。
  • 研究支持糖尿病患者接受EVAR或OSR,需围术期优化和术后监测。

研究设计与样本

  • 系统检索MEDLINE、Embase和Cochrane Library从建库至2025年8月。
  • 纳入比较糖尿病与非糖尿病成人患者接受AAA修复(EVAR或OSR)的对照研究。
  • 共分析14项观察性队列研究,149,206例患者,其中糖尿病30,328例。
  • 采用随机效应Meta分析,并进行亚组和留一法敏感性分析。
  • 使用Newcastle-Ottawa量表评估研究质量。

主要发现

  • 糖尿病与总体30天或5年死亡率无关。
  • EVAR糖尿病患者30天死亡率更高,OSR糖尿病患者无差异。
  • 5年死亡率在EVAR或OSR队列中糖尿病与非糖尿病均无差异。
  • EVAR后糖尿病与5年再干预需求降低相关,但1年无差异。
  • EVAR后内漏率在糖尿病与非糖尿病间相似。

临床怎么用

  • 糖尿病患者可考虑EVAR或OSR,需注重围术期优化和术后监测。
  • EVAR糖尿病患者应关注早期死亡风险,加强围术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes mellitus is common among patients undergoing surgical repair of abdominal aortic aneurysms (AAAs) and is generally associated with adverse surgical outcomes. However, its influence on perioperative and long-term outcomes following AAA repair-whether endovascular (endovascular aneurysm repair [EVAR]) or open surgical repair (OSR)-remains uncertain. This systematic review and meta-analysis aimed to evaluate the association between diabetes and outcomes after AAA repair. METHODS: A systematic search of MEDLINE, Embase, and the Cochrane Library was performed from inception through August 2025. Comparative studies including adult patients with and without diabetes undergoing AAA repair (EVAR or OSR) were included. Primary outcomes were 30-day and long-term (≥5 years) mortality. Secondary outcomes included reintervention at 1 year and ≥5 years. Random-effects meta-analyses were conducted, with subgroup and leave-one-out sensitivity analyses. Study quality was assessed using the Newcastle-Ottawa Scale. RESULTS: Fourteen observational cohort studies including 149,206 patients (30,328 diabetics) were analyzed. Diabetes was not associated with overall 30-day or 5-year mortality. However, diabetics undergoing EVAR had higher 30-day mortality, with no difference observed after OSR. At 5 years, mortality did not differ between diabetics and nondiabetics in EVAR or OSR cohorts. Following EVAR, diabetes was associated with a lower need for reintervention at 5 years but not at 1 year, whereas endoleak rates were similar. CONCLUSION: Diabetes was not associated with worse overall short- or long-term outcomes following AAA repair. Early mortality was higher among diabetic patients undergoing EVAR, whereas long-term outcomes were comparable between EVAR and OSR. These findings support the use of both EVAR and OSR in diabetic patients, with careful perioperative optimization and postoperative surveillance.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nawaz A, Abbas M, Rehman Z, et al. Impact of Diabetes Mellitus on Short- and Long-Term Outcomes after EVAR and Open Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2026. PMID: 41713802. doi:10.1016/j.avsg.2026.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。